Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China
Abstract Background Currently available injectable agents are inadequate to address the high drug-resistant tuberculosis (DR-TB) burden in China. Regimens including the oral agent bedaquiline have been shown to be efficacious and safe, leading to its incorporation into multiple national TB treatment...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
BMC
2020-02-01
|
| سلاسل: | BMC Infectious Diseases |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1186/s12879-020-4795-4 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|